Key result
Stable angina management achieves ~97% guideline therapy use but leaves many hypertensives without effective control.
Why the study?
Data on actual diagnostic and treatment practices for stable angina are sparse and pre-date current guideline recommendations.
Does current real-world management of stable angina align with guideline recommendations and how does it affect quality of life?
Cross-Sectional (n=7,074)
Yes
Does current real-world management of stable angina align with guideline recommendations and how does it affect quality of life?
The management of stable angina frequently falls short of guideline recommendations, particularly in secondary prevention, which negatively impacts patient quality of life.
Inconsistent guideline adherence persists in stable angina diagnosis and secondary prevention; leaves open whether targeted interventions improve outcomes.
BACKGROUND: Stable angina is a growing problem worldwide. Diagnostic methods and treatment regimens are established but data on actual practice are sparse and pre-date current guidance. OBJECTIVES: To compare diagnosis and treatment information with guideline recommendations, and to assess impact on quality of life. METHODS: This international epidemiological survey recruited patients through primary and secondary care clinicians from China, Czech Republic, Greece, Hungary, Portugal, Russia and Slovak Republic. Participants experienced at least one episode of stable angina within the previous four weeks. Outcomes included use of diagnostic techniques, pharmacological treatments, surgical intervention, secondary prevention and quality of life. RESULTS: The study included 7074 patients, average age 63.3 (sd 10.3). Diagnosis of angina was most frequently as a result of chest pains (87.4%) with confirmation by resting ECG in only 54.9%. Advice regarding risk factors was frequently given although secondary prevention was often ineffective with 41% of treated hypertensives lacking effective control. 97% of patients were taking at least one of the primary therapies for stable angina recommended by the guidelines with rates of individual therapies varying greatly across countries. Quality of life was lowest in countries with low rates of surgical intervention and poor observance of guidelines on pharmaceutical therapy. CONCLUSION: Results show that the management of patients with stable angina does not meet recommended standards, although the appropriateness of these guidelines in poorer countries needs further investigation. Overall, the survey indicates that improved medical care and risk factor management would enhance prognosis and improve quality of life.
No takes yet. Share an insight, caveat, or question.
J. L. Eastaugh (2004) conducted a cross-sectional in stable angina (n=7,074). Guideline-recommended management was evaluated on Use of diagnostic techniques, pharmacological treatments, surgical intervention, secondary prevention and quality of life. An international survey of 7,074 patients with stable angina found that 97% were taking at least one guideline-recommended primary therapy, but 41% of treated hypertensives lacked effective control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: